Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.

Ognjanovic S, Linabery AM, Charbonneau B, Ross JA.

Cancer. 2009 Sep 15;115(18):4218-26. doi: 10.1002/cncr.24465.

2.

Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.

Turner JH, Richmon JD.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):967-73. doi: 10.1177/0194599811417063. Epub 2011 Aug 26.

PMID:
21873599
3.

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.

Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, Hahn H, Fulda S.

Oncogene. 2010 Dec 2;29(48):6323-30. doi: 10.1038/onc.2010.368. Epub 2010 Sep 6.

PMID:
20818440
4.

Rhabdomyosarcoma in children: a SEER population based study.

Perez EA, Kassira N, Cheung MC, Koniaris LG, Neville HL, Sola JE.

J Surg Res. 2011 Oct;170(2):e243-51. doi: 10.1016/j.jss.2011.03.001. Epub 2011 Mar 29.

PMID:
21529833
5.

Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.

van Gaal JC, Roeffen MH, Flucke UE, van der Laak JA, van der Heijden G, de Bont ES, Suurmeijer AJ, Versleijen-Jonkers YM, van der Graaf WT.

Eur J Cancer. 2013 Nov;49(16):3462-70. doi: 10.1016/j.ejca.2013.06.022. Epub 2013 Jul 15.

PMID:
23867124
6.

Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.

Gerber NK, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, Zhang Z, Wolden S.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):58-63. doi: 10.1016/j.ijrobp.2012.12.016. Epub 2013 Feb 13.

7.

Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.

Ognjanovic S, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Mueller BA, Puumala S, Reynolds P, Von Behren J, Spector L.

Br J Cancer. 2010 Jan 5;102(1):227-31. doi: 10.1038/sj.bjc.6605484. Epub 2009 Dec 8.

8.

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

Williamson D, Missiaglia E, de Reyniès A, Pierron G, Thuille B, Palenzuela G, Thway K, Orbach D, Laé M, Fréneaux P, Pritchard-Jones K, Oberlin O, Shipley J, Delattre O.

J Clin Oncol. 2010 May 1;28(13):2151-8. doi: 10.1200/JCO.2009.26.3814. Epub 2010 Mar 29.

PMID:
20351326
9.

The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study.

Van Gaal JC, Van Der Graaf WT, Rikhof B, Van Hoesel QG, Teerenstra S, Suurmeijer AJ, Flucke UE, Loeffen JL, Sleijfer S, De Bont ES.

Anticancer Res. 2012 Oct;32(10):4485-97.

PMID:
23060577
10.

Trends in childhood cancer incidence in the U.S. (1992-2004).

Linabery AM, Ross JA.

Cancer. 2008 Jan 15;112(2):416-32.

11.

Incidence trends and long-term survival analysis of sinonasal rhabdomyosarcoma.

Sanghvi S, Misra P, Patel NR, Kalyoussef E, Baredes S, Eloy JA.

Am J Otolaryngol. 2013 Nov-Dec;34(6):682-9. doi: 10.1016/j.amjoto.2013.04.012. Epub 2013 Jun 4.

PMID:
23743294
12.

FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Crose LE, Etheridge KT, Chen C, Belyea B, Talbot LJ, Bentley RC, Linardic CM.

Clin Cancer Res. 2012 Jul 15;18(14):3780-90. doi: 10.1158/1078-0432.CCR-10-3063. Epub 2012 May 30.

13.

Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.

Raney RB, Stoner JA, Walterhouse DO, Andrassy RJ, Donaldson SS, Laurie F, Meyer WH, Qualman SJ, Crist WM; Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.

Pediatr Blood Cancer. 2004 Jun;42(7):618-25.

PMID:
15127417
14.

Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?

Blakely ML, Lobe TE, Anderson JR, Donaldson SS, Andrassy RJ, Parham DM, Wharam MD, Qualman SJ, Wiener ES, Grier HE, Crist WM.

J Pediatr Surg. 1999 May;34(5):736-41; discussion 741-2.

PMID:
10359174
15.

Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.

Bisogno G, Compostella A, Ferrari A, Pastore G, Cecchetto G, Garaventa A, Indolfi P, De Sio L, Carli M.

Cancer. 2012 Feb 1;118(3):821-7. doi: 10.1002/cncr.26355. Epub 2011 Jul 12.

16.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

17.

[Rhabdomyosarcoma and extraosseous Ewing's sarcoma].

Harms D, Leuschner I, Krams M, Pilgrim TB, Treuner J.

Verh Dtsch Ges Pathol. 1998;82:83-98. Review. German.

PMID:
10095421
18.

NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.

Tombolan L, Poli E, Martini P, Zin A, Romualdi C, Bisogno G, Lanfranchi G.

Oncotarget. 2017 May 16;8(20):33086-33099. doi: 10.18632/oncotarget.16526.

19.

Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.

Poynter JN, Amatruda JF, Ross JA.

Cancer. 2010 Oct 15;116(20):4882-91. doi: 10.1002/cncr.25454.

20.

Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.

Kohashi K, Oda Y, Yamamoto H, Tamiya S, Takahira T, Takahashi Y, Tajiri T, Taguchi T, Suita S, Tsuneyoshi M.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1097-103. doi: 10.1007/s00432-008-0385-3. Epub 2008 Apr 2.

PMID:
18386058

Supplemental Content

Support Center